Both in Pharmaceuticals
Stoke Therapeutics vs Ultragenyx Pharmaceutical
Over the past year STOK returned +0.7% and RARE returned −51.9%; their daily moves had a correlation of 0.21.
STOK +0.7% RARE −51.9%Growth of $1, one year, split-adjusted
| Metric | STOK | RARE |
|---|---|---|
| Price | $26.29 | $16.10 |
| Market cap | $1.70B | $1.59B |
| Today | −0.23% | −4.05% |
| 1 month | +1.1% | +9.2% |
| 6 months | −20.5% | −35.0% |
| Year to date | −17.2% | −30.0% |
| 1 year | −16.3% | −53.5% |
| Revenue growth (YoY) | −32.5% | +28.1% |
| Gross margin | 100.0% | 84.1% |
| Net margin | −660.8% | −43.0% |
| P/E (TTM) | — | — |
| Price / sales | 61.5× | 2.2× |
| Net cash | $292.8M | $292.0M |
| Dividend yield | — | — |
| Volatility (60d) | 48.1% | 128.4% |
| Short % of float | 18.9% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).